Therapeutic Fraud Prevention Act of 2023

HR 4340, the Therapeutic Fraud Prevention Act of 2023, prohibits paid providers from offering conversion therapy - defined as any commercial service attempting to change a person's sexual orientation or gender identity - and bans advertising that claims such therapy is effective or harmless. It directly affects therapists, counselors, or organizations offering paid conversion therapy services, including those advertising such services. Key provisions make it unlawful to provide, advertise, or facilitate paid conversion therapy, with enforcement led by the Federal Trade Commission (FTC) under consumer protection laws and allowing states to pursue civil actions. The bill explicitly excludes supportive care for gender transition or identity exploration from its definition of prohibited therapy.